Phenoxypropazine (trade name Drazine) is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was introduced as an antidepressant in 1961 but was subsequently withdrawn in 1966 due to hepatotoxicity concerns.
This page contains content from the copyrighted Wikipedia article "Phenoxypropazine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
